# EDGAR Filing Document

**Accession Number:** 0000062709
**File Stem:** 0000062709-25-000067
**Filing Date:** 2025-7
**Character Count:** 67824
**Document Hash:** 3aeda225b0fad0ac137ecf8f921f3ff4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000062709-25-000067.hdr.sgml**: 20250717

**ACCESSION NUMBER**: 0000062709-25-000067

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 17

**CONFORMED PERIOD OF REPORT**: 20250717

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250717

**DATE AS OF CHANGE**: 20250717

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MARSH & MCLENNAN COMPANIES, INC.
- **CENTRAL INDEX KEY:** 0000062709
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSURANCE AGENTS BROKERS & SERVICES [6411]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 362668272
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05998
- **FILM NUMBER:** 251128782

**BUSINESS ADDRESS:**
- **STREET 1:** 1166 AVENUE OF THE AMERICAS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 2123455000

**MAIL ADDRESS:**
- **STREET 1:** 1166 AVENUE OF THE AMERICAS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MARSH & MCLENNAN COMPANIES INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MARLENNAN CORP
- **DATE OF NAME CHANGE:** 19760505

?xml version='1.0' encoding='ASCII'? mmc-20250717

 **UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**_____________________**

---

| | |
|:---|:---|
| **FORM** | **8-K** |

---

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

<u>Date of report (Date of earliest event reported)</u> <u>July 17, 2025</u>

Marsh & McLennan Companies, Inc. <br> (Exact Name of Registrant as Specified in its Charter)

![MarshMcLennan logo.jpg](mmc-20250717_g1.jpg)

Delaware 1-5998 36-2668272 <br> (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS EmployerIdentification No.)

 1166 Avenue of the Americas, <u>New York,</u> <u>NY</u> 10036 <br> (Address of Principal Executive Offices) (Zip Code)

 <u>Registrant's telephone number, including area code</u>  <u>(212)</u> <u>345-5000</u> 

&nbsp;&nbsp;&nbsp;&nbsp;Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

&nbsp;&nbsp;&nbsp;&nbsp;Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading symbol(s) | Name of exchange on which registered |
| Common Stock, par value $1.00 per share | MMC | New York Stock Exchange |
|  |  | NYSE Texas |

---

&nbsp;&nbsp;&nbsp;&nbsp;Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

---

| | |
|:---|:---|
| Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | &nbsp;&nbsp;&nbsp;&nbsp;☐ |

---

------

**Item 2.02&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition**

&nbsp;&nbsp;&nbsp;&nbsp;On July 17, 2025, Marsh & McLennan Companies, Inc. issued a press release reporting financial results for the second quarter ended June 30, 2025, and announcing that a conference call to discuss such results will be held at 8:30 a.m. Eastern time on July 17, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. For purposes of Section 18 of the Securities Exchange Act of 1934, the press release is deemed furnished not filed.

**Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits**

**(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits**

99.1&nbsp;&nbsp;&nbsp;&nbsp; Press release issued by Marsh & McLennan Companies, Inc. on July 17, 2025.

------

**SIGNATURES**

&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| MARSH & McLENNAN COMPANIES, INC. | MARSH & McLENNAN COMPANIES, INC. |
| By: | /s/ Connor Kuratek |
| Name: | Connor Kuratek |
| Title: | Deputy General Counsel &<br>Corporate Secretary |

---

Date:&nbsp;&nbsp;&nbsp;&nbsp;July 17, 2025

------

**EXHIBIT INDEX**

<u>Exhibit No.</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Exhibit</u>

<u>[99.1](mmc2q2025ex991newsrelease.htm)</u> <u>[Press release issued by Marsh & McLennan Companies, Inc. on July 17, 2025](mmc2q2025ex991newsrelease.htm)</u>

## Exhibit 99.1

---

| | |
|:---|:---|
| ![marshmclennanlogoa.jpg](marshmclennanlogoa.jpg) |  |
| | Marsh McLennan <br>1166 Avenue of the Americas<br>New York, New York <br>10036-2774<br>+1 212 345 5000<br>www.marshmclennan.com |

---

---

| | |
|:---|:---|
| **News release**  | Exhibit 99.1 |

---

**Marsh McLennan reports second quarter 2025 results** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Revenue Growth of 12%; Underlying Revenue Growth of 4%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** GAAP Operating Income Increases 11%; Adjusted Operating Income Increases 14%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Second Quarter GAAP EPS of $2.45; Adjusted EPS Increases 11% to $2.72

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Six Months GAAP EPS of $5.23; Adjusted EPS Increases 8% to $5.78

**NEW YORK**, July 17, 2025 – Marsh McLennan (NYSE: MMC), the world's leading professional services firm in the areas of risk, strategy and people, today reported financial results for the second quarter ended June 30, 2025.

John Doyle, President and CEO, said: "We had another solid quarter with 12% revenue growth reflecting continued momentum across our business and the contribution from acquisitions. We generated 4% underlying revenue growth, 14% growth in adjusted operating income, and 11% growth in adjusted EPS. In addition, we recently announced a 10% increase in our dividend."

"Our performance demonstrates the enduring value we provide to clients, as well as our consistent execution in a complex and dynamic environment."

<u>Consolidated Results</u>

Consolidated revenue in the second quarter of 2025 was $7.0 billion, an increase of 12% compared with the second quarter of 2024, or 4% on an underlying basis. Operating income rose 11% to $1.8 billion. Adjusted operating income, which excludes noteworthy items and identified intangible amortization expense as presented in the attached supplemental schedules, rose 14% to $2.1 billion. Net income attributable to the Company was $1.2 billion. Earnings per share increased 8% to $2.45. Adjusted earnings per share increased 11% to $2.72.

![imagea.jpg](imagea.jpg)<br>

------

For the six months ended June 30, 2025, consolidated revenue was $14.0 billion, an increase of 11% on a GAAP basis or 4% on an underlying basis, compared to the prior year period. Operating income was $3.8 billion, an increase of 7% from the prior year period. Adjusted operating income rose 11% to $4.3 billion. Net income attributable to the Company was $2.6 billion, or $5.23 per diluted share, compared with $5.08 in the first six months of 2024. Adjusted earnings per share increased 8% to $5.78.

<u>Risk & Insurance Services</u>

Risk & Insurance Services revenue was $4.6 billion in the second quarter of 2025, an increase of 15%, or 4% on an underlying basis. Operating income increased 11% to $1.4 billion, while adjusted operating income increased 16% to $1.6 billion. For the six months ended June 30, 2025, revenue was $9.4 billion, an increase of 13%, or 4% on an underlying basis. Operating income rose 7% to $3.1 billion, and adjusted operating income increased 12% to $3.5 billion.

Marsh's revenue in the second quarter of 2025 was $3.8 billion, an increase of 18%, or 5% on an underlying basis. In U.S./Canada, underlying revenue rose 4%. International operations produced underlying revenue growth of 7%, including 8% in EMEA, 4% in Asia Pacific, and 3% in Latin America. For the six months ended June 30, 2025, Marsh's underlying revenue growth was 5%.

Guy Carpenter's revenue in the second quarter was $677 million, an increase of 7%, or 5% on underlying basis. For the six months ended June 30, 2025, Guy Carpenter's underlying revenue growth was 5%.

<u>Consulting</u>

Consulting revenue was $2.4 billion in the second quarter of 2025, an increase of 7%, or 3% on an underlying basis. Operating income increased 11% to $456 million, while adjusted operating income increased 9% to $479 million. For the first six months ended June 30, 2025, revenue was $4.7 billion, an increase of 6%, or 4% on an underlying basis. Operating income rose 8% to $912 million, and adjusted operating income increased 9% to $970 million.

Mercer's revenue in the second quarter was $1.5 billion, an increase of 9%, or 3% on an underlying basis. Wealth revenue increased 2% on an underlying basis, Health revenue increased 7% on an underlying basis, and Career revenue decreased 5% on an underlying basis. For the six months ended June 30, 2025, Mercer's revenue was $3.0 billion, an increase of 3% on an underlying basis.

Oliver Wyman's revenue in the second quarter of 2025 was $873 million, an increase of 5%, or 3% on an underlying basis. For the six months ended June 30, 2025, Oliver Wyman's revenue was $1.7 billion, an increase of 4% on an underlying basis.

<u>Other Items</u>

The Company repurchased 1.4 million shares of stock for $300 million in the second quarter of 2025.

Through six months ended June 30, 2025, the Company has repurchased 2.7 million shares of stock for $600 million.

Last week, the Board of Directors increased the quarterly dividend 10% to $0.900 per share, with the third quarter dividend payable on August 15, 2025.

------

<u>Conference Call</u>

A conference call to discuss second quarter 2025 results will be held today at 8:30 a.m. Eastern time. The live audio webcast may be accessed at marshmclennan.com. A replay of the webcast will be available approximately two hours after the event. The webcast is listen-only. Those interested in participating in the question-and-answer session may register here to receive the dial-in numbers and unique PIN to access the call.

**About Marsh McLennan**

Marsh McLennan (NYSE: MMC) is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit marshmclennan.com, or follow us on LinkedIn and X.

------

**INFORMATION CONCERNING FORWARD-LOOKING STATEMENTS**

This press release contains "forward-looking statements," as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management's current views concerning future events or results, use words like "anticipate," "assume," "believe," "continue," "estimate," "expect," "intend," "plan," "project" and similar terms, and future or conditional tense verbs like "could," "may," "might," "should," "will" and "would".

Forward-looking statements are subject to inherent risks and uncertainties that could cause actual results to differ materially from those expressed or implied in our forward-looking statements. Factors that could materially affect our future results include, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of geopolitical or macroeconomic conditions on us, our clients and the countries and industries in which we operate, including from multiple major wars and global conflicts, tariffs or changes in trade policies, slower GDP growth or recession, fluctuations in foreign exchange rates, lower interest rates, capital markets volatility, inflation and changes in insurance premium rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact from lawsuits or investigations arising from errors and omissions, breaches of fiduciary duty or other claims against us in our capacity as a broker or investment advisor, including claims related to our investment business' ability to execute timely trades;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the increasing prevalence of ransomware, supply chain and other forms of cyber attacks, and their potential to disrupt our operations, or the operations of our third party vendors, and result in the disclosure of confidential client or company information;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the financial and operational impact of complying with laws and regulations, including domestic and international sanctions regimes, anti-corruption laws such as the U.S. Foreign Corrupt Practices Act, U.K. Anti Bribery Act and cybersecurity, data privacy and artificial intelligence regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to attract, retain and develop industry leading talent;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to compete effectively and adapt to competitive pressures in each of our businesses, including from disintermediation as well as technological change, digital disruption and other types of innovation such as artificial intelligence;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to manage potential conflicts of interest, including where our services to a client conflict, or are perceived to conflict, with the interests of another client or our own interests;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of changes in tax laws, guidance and interpretations, such as the implementation of the Organization for Economic Cooperation and Development international tax framework, or the increasing number of challenges from tax authorities in the current global tax environment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the regulatory, contractual and reputational risks that arise based on insurance placement activities and insurer revenue streams;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to design and execute operating model changes that capture opportunities and efficiencies at the intersection of our businesses; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully integrate or achieve the intended benefits of the acquisition of McGriff.

The factors identified above are not exhaustive. Marsh McLennan and its subsidiaries (collectively, the "Company") operate in a dynamic business environment in which new risks emerge frequently. Accordingly, we caution readers not to place undue reliance on any forward-looking statements, which are based only on information currently available to us and speak only as of the dates on which they are made. The Company undertakes no obligation to update or revise any forward-looking statement to reflect events or circumstances arising after the date on which it is made.

Further information concerning the Company, including information about factors that could materially affect our results of operations and financial condition, is contained in the Company's filings with the Securities and Exchange Commission, including the "Risk Factors" section and the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section of our most recently filed Annual Report on Form 10-K.

------

**Marsh & McLennan Companies, Inc.**

**Consolidated Statements of Income**

(In millions, except per share data)

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br> June 30,** | **Three Months Ended<br> June 30,** | **Six Months Ended<br> June 30,** | **Six Months Ended<br> June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| **Revenue** | $**6974** | $6221 | $**14035** | $12694 |
| **Expense:** |  |  |  |  |
| Compensation and benefits | **3895** | 3454 | **7745** | 6924 |
| Other operating expenses | **1250** | 1125 | **2456** | 2203 |
| &nbsp;&nbsp;&nbsp;&nbsp; **Operating expenses** | **5145** | 4579 | **10201** | 9127 |
| **Operating income** | **1829** | 1642 | **3834** | 3567 |
| **Other net benefit credits** | **48** | 66 | **91** | 133 |
| **Interest income** | **5** | 12 | **24** | 49 |
| **Interest expense** | **(243)** | (156) | **(488)** | (315) |
| **Investment income** | **7** | 1 | **12** | 2 |
| **Income before income taxes** | **1646** | 1565 | **3473** | 3436 |
| **Income tax expense** | **415** | 425 | **830** | 872 |
| **Net income before non-controlling interests** | **1231** | 1140 | **2643** | 2564 |
| **Less: Net income attributable to non-controlling interests** | **20** | 15 | **51** | 39 |
| **Net income attributable to the Company** | $**1211** | $1125 | $**2592** | $2525 |
| **Net income per share attributable to the Company:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**- Basic** | $**2.46** | $2.28 | $**5.27** | $5.13 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**- Diluted** | $**2.45** | $2.27 | $**5.23** | $5.08 |
| **Average number of shares outstanding:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**- Basic** | **492** | 492 | **492** | 492 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**- Diluted** | **495** | 496 | **495** | 497 |
| **Shares outstanding at June 30** | **492** | 492 | **492** | 492 |

---

------

**Marsh & McLennan Companies, Inc.** 

**Supplemental Information - Revenue Analysis**

**Three Months Ended June 30** 

(Millions) (Unaudited)

The Company advises clients in 130 countries. As a result, foreign exchange rate movements may impact period over period comparisons of revenue. Similarly, certain other items such as acquisitions and dispositions, including transfers among businesses, may impact period over period comparisons of revenue. Non-GAAP underlying revenue measures the change in revenue from one period to the next by isolating these impacts.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | **Components of Revenue Change\*** | **Components of Revenue Change\*** | **Components of Revenue Change\*** |
| | **Three Months Ended<br> June 30,** | **Three Months Ended<br> June 30,** | **% Change<br>GAAP Revenue\*** | **Currency Impact** | **Acquisitions/<br>Dispositions/ Other Impact\*\*** | **Non-GAAP<br>Underlying Revenue** |
| | **2025** | 2024 | **% Change<br>GAAP Revenue\*** | **Currency Impact** | **Acquisitions/<br>Dispositions/ Other Impact\*\*** | **Non-GAAP<br>Underlying Revenue** |
| **Risk and Insurance Services** |  |  |  |  |  |  |
| Marsh (a) | $**3849** | $3265 | 18% | 1% | 12% | 5% |
| Guy Carpenter | **677** | 632 | 7% | 1% | 1% | 5% |
| &nbsp;&nbsp;&nbsp;&nbsp; Subtotal | **4526** | 3897 | 16% | 1% | 10% | 5% |
| Fiduciary interest income | **99** | 125 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Risk and Insurance Services | **4625** | 4022 | 15% | 1% | 10% | 4% |
| **Consulting** |  |  |  |  |  |  |
| Mercer | **1498** | 1379 | 9% | 1% | 4% | 3% |
| Oliver Wyman Group | **873** | 837 | 5% | 1% | &nbsp;&nbsp;— | 3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Consulting | **2371** | 2216 | 7% | 1% | 3% | 3% |
| **Corporate Eliminations** | **(22)** | (17) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;**Total Revenue** | $**6974** | $6221 | 12% | 1% | 8% | 4% |

---

**Revenue Details**

The following table provides more detailed revenue information for certain of the components presented above:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | **Components of Revenue Change\*** | **Components of Revenue Change\*** | **Components of Revenue Change\*** |
| | **Three Months Ended<br> June 30,** | **Three Months Ended<br> June 30,** | **% Change<br>GAAP Revenue\*** | **Currency Impact** | **Acquisitions/<br>Dispositions/ Other Impact\*\*** | **Non-GAAP<br>Underlying Revenue** |
| | **2025** | 2024 | **% Change<br>GAAP Revenue\*** | **Currency Impact** | **Acquisitions/<br>Dispositions/ Other Impact\*\*** | **Non-GAAP<br>Underlying Revenue** |
| **Marsh:** |  |  |  |  |  |  |
| EMEA | $**1006** | $912 | 10% | 3% | &nbsp;&nbsp;— | 8% |
| Asia Pacific | **409** | 391 | 4% | &nbsp;&nbsp;— | (1)% | 4% |
| Latin America | **132** | 137 | (4)% | (5)% | (1)% | 3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total International | **1547** | 1440 | 7% | 1% | (1)% | 7% |
| U.S./Canada (a) | **2302** | 1825 | 26% | &nbsp;&nbsp;— | 22% | 4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Marsh | $**3849** | $3265 | 18% | 1% | 12% | 5% |
| **Mercer:** |  |  |  |  |  |  |
| Wealth | $**685** | $612 | 12% | 2% | 8% | 2% |
| Health | **594** | 547 | 9% | &nbsp;&nbsp;— | 1% | 7% |
| Career | **219** | 220 | (1)% | 1% | 3% | (5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Mercer | $**1498** | $1379 | 9% | 1% | 4% | 3% |

---

---

| |
|:---|
| (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff.  |
| \* Rounded to whole percentages. Components of revenue may not add due to rounding.<br>\*\* Acquisitions, dispositions, and other includes the impact of current and prior year items excluded from the calculation of non-GAAP underlying revenue for comparability purposes. Details on these items are provided in the reconciliation of non-GAAP revenue to GAAP revenue tables included in this release. |

---

------

**Marsh & McLennan Companies, Inc.**

**Supplemental Information - Revenue Analysis**

**Six Months Ended June 30** 

(Millions) (Unaudited)

The Company advises clients in 130 countries. As a result, foreign exchange rate movements may impact period over period comparisons of revenue. Similarly, certain other items such as acquisitions and dispositions, including transfers among businesses, may impact period over period comparisons of revenue. Non-GAAP underlying revenue measures the change in revenue from one period to the next by isolating these impacts.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | **Components of Revenue Change\*** | **Components of Revenue Change\*** | **Components of Revenue Change\*** |
| | **Six Months Ended<br> June 30,** | **Six Months Ended<br> June 30,** | **% Change<br>GAAP Revenue\*** | **Currency Impact** | **Acquisitions/<br>Dispositions/ Other Impact\*\*** | **Non-GAAP<br>Underlying Revenue** |
| | **2025** | 2024 | **% Change<br>GAAP Revenue\*** | **Currency Impact** | **Acquisitions/<br>Dispositions/ Other Impact\*\*** | **Non-GAAP<br>Underlying Revenue** |
| **Risk and Insurance Services** |  |  |  |  |  |  |
| Marsh (a) | $**7302** | $6268 | 16% | (1)% | 12% | 5% |
| Guy Carpenter | **1883** | 1780 | 6% |  | 1% | 5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | **9185** | 8048 | 14% | (1)% | 10% | 5% |
| Fiduciary interest income | **202** | 247 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Total Risk and Insurance Services | **9387** | 8295 | 13% | (1)% | 9% | 4% |
| **Consulting** |  |  |  |  |  |  |
| Mercer (b) | **2994** | 2804 | 7% | (1)% | 4% | 3% |
| Oliver Wyman Group | **1691** | 1626 | 4% |  |  | 4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Consulting | **4685** | 4430 | 6% |  | 3% | 4% |
| **Corporate Eliminations** | **(37)** | (31) |  |  |  |  |
| &nbsp;&nbsp;&nbsp; **Total Revenue** | $**14035** | $12694 | 11% |  | 7% | 4% |

---

**Revenue Details**

The following table provides more detailed revenue information for certain of the components presented above:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | **Components of Revenue Change\*** | **Components of Revenue Change\*** | **Components of Revenue Change\*** |
| | **Six Months Ended<br> June 30,** | **Six Months Ended<br> June 30,** | **% Change<br>GAAP Revenue\*** | **Currency Impact** | **Acquisitions/<br>Dispositions/ Other Impact\*\*** | **Non-GAAP<br>Underlying Revenue** |
| | **2025** | 2024 | **% Change<br>GAAP Revenue\*** | **Currency Impact** | **Acquisitions/<br>Dispositions/ Other Impact\*\*** | **Non-GAAP<br>Underlying Revenue** |
| **Marsh:** |  |  |  |  |  |  |
| EMEA | $**2065** | $1937 | 7% |  |  | 7% |
| Asia Pacific | **744** | 727 | 2% | (1)% | (1)% | 4% |
| Latin America | **256** | 262 | (2)% | (7)% | (1)% | 5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total International | **3065** | 2926 | 5% | (1)% | (1)% | 6% |
| U.S./Canada (a) | **4237** | 3342 | 27% |  | 23% | 4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Marsh | $**7302** | $6268 | 16% | (1)% | 12% | 5% |
| **Mercer:** |  |  |  |  |  |  |
| Wealth (b) | $**1355** | $1284 | 6% |  | 3% | 3% |
| Health (b) | **1202** | 1085 | 11% | (1)% | 5% | 7% |
| Career | **437** | 435 |  |  | 4% | (3)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Mercer | $**2994** | $2804 | 7% | (1)% | 4% | 3% |

---

---

| |
|:---|
| (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. <br>(b)Acquisitions, dispositions and other in 2024 includes a net gain from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a gain in Wealth, offset by a loss in Health. |
| \* Rounded to whole percentages. Components of revenue may not add due to rounding.<br>\*\* Acquisitions, dispositions and other includes the impact of current and prior year items excluded from the calculation of non-GAAP underlying revenue for comparability purposes. Details on these items are provided in the reconciliation of non-GAAP revenue to GAAP revenue tables included in this release. |

---

------

**Marsh & McLennan Companies, Inc.**

**Reconciliation of Non-GAAP Measures**

**Three Months Ended June 30**

(Millions) (Unaudited)

**Overview**

The Company reports its financial results in accordance with accounting principles generally accepted in the United States (referred to in this release as in accordance with "GAAP" or "reported" results). The Company also refers to and presents certain additional non-GAAP financial measures, within the meaning of Regulation G and item 10(e) Regulation S-K in accordance with the Securities Exchange Act of 1934. These measures are: *non-GAAP revenue, adjusted operating income (loss)*, *adjusted operating margin, adjusted income, net of tax* and *adjusted earnings per share (EPS)*. The Company has included reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated in accordance with GAAP in the following tables.

The Company believes these non-GAAP financial measures provide useful supplemental information that enables investors to better compare the Company's performance across periods. Management also uses these measures internally to assess the operating performance of its businesses and to decide how to allocate resources. However, investors should not consider these non-GAAP measures in isolation from, or as a substitute for, the financial information that the Company reports in accordance with GAAP. The Company's non-GAAP measures include adjustments that reflect how management views its businesses, and may differ from similarly titled non-GAAP measures presented by other companies.

In the first quarter of 2025, the Company changed its methodology to report adjusted operating income (loss), adjusted income, net of tax and adjusted EPS to exclude the impact of intangible amortization and other net benefit credits. Prior year results are presented using the new methodology for comparative purposes.

**Adjusted Operating Income (Loss) and Adjusted Operating Margin**

*Adjusted operating income (loss)* is calculated by excluding the impact of certain noteworthy items and identified intangible amortization expense from the Company's GAAP operating income (loss). The following tables reconcile *adjusted operating income (loss*) to GAAP operating income (loss) on a consolidated and reportable segment basis for the three and six months ended June 30, 2025 and 2024. The following tables also present *adjusted operating margin.* For the three and six months ended June 30, 2025 and 2024, *adjusted operating margin* is calculated by dividing the sum of *adjusted operating income* by consolidated or segment adjusted revenue. The Company's adjusted revenue used in the determination of *adjusted operating margin* is calculated by excluding the impact of certain noteworthy items from the Company's GAAP revenue.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Risk & Insurance Services** | **Consulting** | **Corporate/<br>Eliminations** | **Total** |
| **Three Months Ended June 30, 2025** | | | | |
| **Operating income (loss)** | $**1443** | $**456** | $**(70)** | $**1829** |
| **Operating margin** | **31.2%** | **19.2%** | **N/A** | **26.2%** |
| Add (deduct) impact of noteworthy items: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring (a) | **8** | **6** | **4** | **18** |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in contingent and deferred consideration (b) | **27** | **1** | **—** | **28** |
| &nbsp;&nbsp;&nbsp;&nbsp;McGriff integration and retention related costs | **45** | **—** | **—** | **45** |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition related costs (c) | **—** | **3** | **—** | **3** |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition and disposition related gains (d) | **—** | **(6)** | **—** | **(6)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total noteworthy items | **80** | **4** | **4** | **88** |
| &nbsp;&nbsp;&nbsp;&nbsp;Identified intangible amortization expense | **121** | **19** | **—** | **140** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Operating income adjustments** | **201** | **23** | **4** | **228** |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income (loss) | $**1644** | $**479** | $**(66)** | $**2057** |
| **Adjusted operating margin** | **35.6%** | **20.2%** | **N/A** | **29.5%** |
| **Three Months Ended June 30, 2024** |  |  |  |  |
| **Operating income (loss)** | $1297 | $410 | $(65) | $1642 |
| **Operating margin** | 32.2% | 18.5% | N/A | 26.4% |
| Add (deduct) impact of noteworthy items: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring (a) | 29 | 5 | 10 | 44 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in contingent and deferred consideration (b) | 7 | 2 |  | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition related costs (c) | 11 | 9 |  | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total noteworthy items | 47 | 16 | 10 | 73 |
| &nbsp;&nbsp;&nbsp;&nbsp;Identified intangible amortization expense | 77 | 12 |  | 89 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Operating income adjustments** | 124 | 28 | 10 | 162 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income (loss) | $1421 | $438 | $(55) | $1804 |
| **Adjusted operating margin** | 35.3% | 19.8% | N/A | 29.0% |
| &nbsp;&nbsp;(a)Costs in 2025 include severance and lease exit charges for restructuring activities. Costs in 2024 include severance and lease exit charges for activities focused on workforce actions, rationalization of technology and functional resources, and reductions in real estate. <br>(b)Reflects the change in the fair value of contingent consideration and deferred acquisition related costs.<br>(c)Reflects one-time acquisition and disposition related retention and other costs. <br>(d)Adjustment to the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses, transacted in the first quarter of 2024. This amount is included in revenue in the consolidated statements of income and excluded from non-GAAP underlying revenue and adjusted revenue used in the calculation of adjusted operating margin. | &nbsp;&nbsp;(a)Costs in 2025 include severance and lease exit charges for restructuring activities. Costs in 2024 include severance and lease exit charges for activities focused on workforce actions, rationalization of technology and functional resources, and reductions in real estate. <br>(b)Reflects the change in the fair value of contingent consideration and deferred acquisition related costs.<br>(c)Reflects one-time acquisition and disposition related retention and other costs. <br>(d)Adjustment to the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses, transacted in the first quarter of 2024. This amount is included in revenue in the consolidated statements of income and excluded from non-GAAP underlying revenue and adjusted revenue used in the calculation of adjusted operating margin. | &nbsp;&nbsp;(a)Costs in 2025 include severance and lease exit charges for restructuring activities. Costs in 2024 include severance and lease exit charges for activities focused on workforce actions, rationalization of technology and functional resources, and reductions in real estate. <br>(b)Reflects the change in the fair value of contingent consideration and deferred acquisition related costs.<br>(c)Reflects one-time acquisition and disposition related retention and other costs. <br>(d)Adjustment to the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses, transacted in the first quarter of 2024. This amount is included in revenue in the consolidated statements of income and excluded from non-GAAP underlying revenue and adjusted revenue used in the calculation of adjusted operating margin. | &nbsp;&nbsp;(a)Costs in 2025 include severance and lease exit charges for restructuring activities. Costs in 2024 include severance and lease exit charges for activities focused on workforce actions, rationalization of technology and functional resources, and reductions in real estate. <br>(b)Reflects the change in the fair value of contingent consideration and deferred acquisition related costs.<br>(c)Reflects one-time acquisition and disposition related retention and other costs. <br>(d)Adjustment to the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses, transacted in the first quarter of 2024. This amount is included in revenue in the consolidated statements of income and excluded from non-GAAP underlying revenue and adjusted revenue used in the calculation of adjusted operating margin. | &nbsp;&nbsp;(a)Costs in 2025 include severance and lease exit charges for restructuring activities. Costs in 2024 include severance and lease exit charges for activities focused on workforce actions, rationalization of technology and functional resources, and reductions in real estate. <br>(b)Reflects the change in the fair value of contingent consideration and deferred acquisition related costs.<br>(c)Reflects one-time acquisition and disposition related retention and other costs. <br>(d)Adjustment to the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses, transacted in the first quarter of 2024. This amount is included in revenue in the consolidated statements of income and excluded from non-GAAP underlying revenue and adjusted revenue used in the calculation of adjusted operating margin. |

---

------

**Marsh & McLennan Companies, Inc.**

**Reconciliation of Non-GAAP Measures** 

**Six Months Ended June 30**

(Millions) (Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Risk & Insurance Services** | **Consulting** | **Corporate/<br>Eliminations** | **Total** |
| **Six Months Ended June 30, 2025** | | | | |
| **Operating income (loss)** | $**3056** | $**912** | $**(134)** | $**3834** |
| **Operating margin** | **32.6%** | **19.5%** | **N/A** | **27.3%** |
| Add (deduct) impact of noteworthy items: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring (a) | **31** | **14** | **5** | **50** |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in contingent and deferred consideration (b) | **30** | **7** | **—** | **37** |
| &nbsp;&nbsp;&nbsp;&nbsp;McGriff integration and retention related costs | **114** | **—** | **—** | **114** |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition related costs (c) | **7** | **5** | **—** | **12** |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition and disposition related gains (d) | **(28)** | **(6)** | **—** | **(34)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total noteworthy items | **154** | **20** | **5** | **179** |
| &nbsp;&nbsp;&nbsp;&nbsp;Identified intangible amortization expense | **241** | **38** | **—** | **279** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Operating income adjustments** | **395** | **58** | **5** | **458** |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income (loss) | $**3451** | $**970** | $**(129)** | $**4292** |
| **Adjusted operating margin** | **36.9%** | **20.7%** | **N/A** | **30.7%** |
| **Six Months Ended June 30, 2024**  |  |  |  |  |
| **Operating income (loss)** | $2862 | $842 | $(137) | $3567 |
| **Operating margin** | 34.5% | 19.0% | N/A | 28.1% |
| Add (deduct) impact of noteworthy items: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring (a) | 51 | 16 | 19 | 86 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in contingent and deferred consideration (b) | 12 | 3 |  | 15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition related costs (c) | 12 | 30 |  | 42 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition and disposition related gains (d) |  | (21) |  | (21) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total noteworthy items | 75 | 28 | 19 | 122 |
| &nbsp;&nbsp;&nbsp;&nbsp;Identified intangible amortization expense | 156 | 23 |  | 179 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Operating income adjustments** | 231 | 51 | 19 | 301 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating income (loss) | $3093 | $893 | $(118) | $3868 |
| **Adjusted operating margin** | 37.3% | 20.3% | N/A | 30.5% |
| &nbsp;&nbsp;(a)Costs in 2025 include severance and lease exit charges for restructuring activities. Costs in 2024 include severance and lease exit charges for activities focused on workforce actions, rationalization of technology and functional resources, and reductions in real estate. <br>(b)Reflects the change in the fair value of contingent consideration and deferred acquisition related costs.<br>(c)Reflects one-time acquisition and disposition related retention and other costs.<br>(d)RIS in 2025 includes a gain on the sale of a business and a gain on the remeasurement of an investment. Consulting in 2024 includes the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses, which was adjusted in 2025. These amounts are included in revenue in the consolidated statements of income and excluded from non-GAAP underlying revenue and adjusted revenue used in the calculation of adjusted operating margin. | &nbsp;&nbsp;(a)Costs in 2025 include severance and lease exit charges for restructuring activities. Costs in 2024 include severance and lease exit charges for activities focused on workforce actions, rationalization of technology and functional resources, and reductions in real estate. <br>(b)Reflects the change in the fair value of contingent consideration and deferred acquisition related costs.<br>(c)Reflects one-time acquisition and disposition related retention and other costs.<br>(d)RIS in 2025 includes a gain on the sale of a business and a gain on the remeasurement of an investment. Consulting in 2024 includes the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses, which was adjusted in 2025. These amounts are included in revenue in the consolidated statements of income and excluded from non-GAAP underlying revenue and adjusted revenue used in the calculation of adjusted operating margin. | &nbsp;&nbsp;(a)Costs in 2025 include severance and lease exit charges for restructuring activities. Costs in 2024 include severance and lease exit charges for activities focused on workforce actions, rationalization of technology and functional resources, and reductions in real estate. <br>(b)Reflects the change in the fair value of contingent consideration and deferred acquisition related costs.<br>(c)Reflects one-time acquisition and disposition related retention and other costs.<br>(d)RIS in 2025 includes a gain on the sale of a business and a gain on the remeasurement of an investment. Consulting in 2024 includes the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses, which was adjusted in 2025. These amounts are included in revenue in the consolidated statements of income and excluded from non-GAAP underlying revenue and adjusted revenue used in the calculation of adjusted operating margin. | &nbsp;&nbsp;(a)Costs in 2025 include severance and lease exit charges for restructuring activities. Costs in 2024 include severance and lease exit charges for activities focused on workforce actions, rationalization of technology and functional resources, and reductions in real estate. <br>(b)Reflects the change in the fair value of contingent consideration and deferred acquisition related costs.<br>(c)Reflects one-time acquisition and disposition related retention and other costs.<br>(d)RIS in 2025 includes a gain on the sale of a business and a gain on the remeasurement of an investment. Consulting in 2024 includes the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses, which was adjusted in 2025. These amounts are included in revenue in the consolidated statements of income and excluded from non-GAAP underlying revenue and adjusted revenue used in the calculation of adjusted operating margin. | &nbsp;&nbsp;(a)Costs in 2025 include severance and lease exit charges for restructuring activities. Costs in 2024 include severance and lease exit charges for activities focused on workforce actions, rationalization of technology and functional resources, and reductions in real estate. <br>(b)Reflects the change in the fair value of contingent consideration and deferred acquisition related costs.<br>(c)Reflects one-time acquisition and disposition related retention and other costs.<br>(d)RIS in 2025 includes a gain on the sale of a business and a gain on the remeasurement of an investment. Consulting in 2024 includes the net gain on sale of the Mercer U.K. pension administration and U.S. health and benefits administration businesses, which was adjusted in 2025. These amounts are included in revenue in the consolidated statements of income and excluded from non-GAAP underlying revenue and adjusted revenue used in the calculation of adjusted operating margin. |

---

------

**Marsh & McLennan Companies, Inc.**

 **Reconciliation of Non-GAAP Measures**

**Three and Six Months Ended June 30** 

(In millions, except per share data)

(Unaudited)

*Adjusted income, net of tax* is calculated as the Company's GAAP income from continuing operations, adjusted to reflect the after tax impact of the operating income adjustments in the preceding tables and the additional items listed below. *Adjusted EPS* is calculated by dividing the Company's *adjusted income, net of tax*, by the average number of shares outstanding-diluted for the relevant period. The following tables reconcile *adjusted income, net of tax* to GAAP income from continuing operations and *adjusted EPS* to GAAP EPS for the three and six months ended June 30, 2025 and 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br> June 30, 2025** | **Three Months Ended<br> June 30, 2025** | **Three Months Ended<br> June 30, 2025** | Three Months Ended<br> June 30, 2024 | Three Months Ended<br> June 30, 2024 | Three Months Ended<br> June 30, 2024 |
| | **Amount** | **Amount** | **Adjusted EPS** | Amount | Amount | Adjusted EPS |
| Net income before non-controlling interests, as reported |  | $**1231** |  |  | $1140 |  |
| Less: Non-controlling interest, net of tax |  | **20** |  |  | 15 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal |  | $**1211** | $**2.45** |  | $1125 | $2.27 |
| Operating income adjustments | $**228** |  |  | $162 |  |  |
| Other net benefit credits | **(48)** |  |  | (66) |  |  |
| Investments adjustment | **1** |  |  | (1) |  |  |
| Income tax effect of adjustments (a) | **(46)** |  |  | (10) |  |  |
|  |  | **135** | **0.27** |  | 85 | 0.17 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted income, net of tax |  | $**1346** | $**2.72** |  | $1210 | $2.44 |
|  | **Six Months Ended <br> June 30, 2025** | **Six Months Ended <br> June 30, 2025** | **Six Months Ended <br> June 30, 2025** | Six Months Ended <br> June 30, 2024 | Six Months Ended <br> June 30, 2024 | Six Months Ended <br> June 30, 2024 |
|  | **Amount** | **Amount** | **Adjusted EPS** | Amount | Amount | Adjusted EPS |
| Net income before non-controlling interests, as reported |  | $**2643** |  |  | $2564 |  |
| Less: Non-controlling interest, net of tax |  | **51** |  |  | 39 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal |  | $**2592** | $**5.23** |  | $2525 | $5.08 |
| Operating income adjustments | $**458** |  |  | $301 |  |  |
| Other net benefit credits | **(91)** |  |  | (133) |  |  |
| Investments adjustment | **(1)** |  |  | (2) |  |  |
| Income tax effect of adjustments (a) | **(96)** |  |  | (28) |  |  |
|  |  | **270** | **0.55** |  | 138 | 0.28 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted income, net of tax |  | $**2862** | $**5.78** |  | $2663 | $5.36 |
| (a)For items with an income tax impact, the tax effect was calculated using an estimated effective tax rate for each item based on jurisdiction with a blended rate for items occurring in multiple jurisdictions. | (a)For items with an income tax impact, the tax effect was calculated using an estimated effective tax rate for each item based on jurisdiction with a blended rate for items occurring in multiple jurisdictions. | (a)For items with an income tax impact, the tax effect was calculated using an estimated effective tax rate for each item based on jurisdiction with a blended rate for items occurring in multiple jurisdictions. | (a)For items with an income tax impact, the tax effect was calculated using an estimated effective tax rate for each item based on jurisdiction with a blended rate for items occurring in multiple jurisdictions. | (a)For items with an income tax impact, the tax effect was calculated using an estimated effective tax rate for each item based on jurisdiction with a blended rate for items occurring in multiple jurisdictions. | (a)For items with an income tax impact, the tax effect was calculated using an estimated effective tax rate for each item based on jurisdiction with a blended rate for items occurring in multiple jurisdictions. | (a)For items with an income tax impact, the tax effect was calculated using an estimated effective tax rate for each item based on jurisdiction with a blended rate for items occurring in multiple jurisdictions. |

---

------

**Marsh & McLennan Companies, Inc.**

**Supplemental Information**

**Three and Six Months Ended June 30**

(Millions) (Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br> June 30,** | **Three Months Ended<br> June 30,** | **Six Months Ended <br> June 30,** | **Six Months Ended <br> June 30,** |
| | **2025** | 2024 | **2025** | 2024 |
| **Consolidated** |  |  |  |  |
| Compensation and benefits | $**3895** | $3454 | $**7745** | $6924 |
| Other operating expenses | **1250** | 1125 | **2456** | 2203 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total expenses | $**5145** | $4579 | $**10201** | $9127 |
| Depreciation and amortization expense | $**91** | $87 | $**179** | $186 |
| Identified intangible amortization expense | **140** | 89 | **279** | 179 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $**231** | $176 | $**458** | $365 |
| **Risk and Insurance Services** |  |  |  |  |
| Compensation and benefits  | $**2462** | $2108 | $**4913** | $4226 |
| Other operating expenses | **720** | 617 | **1418** | 1207 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total expenses | $**3182** | $2725 | $**6331** | $5433 |
| Depreciation and amortization expense | $**51** | $46 | $**101** | $92 |
| Identified intangible amortization expense | **121** | 77 | **241** | 156 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $**172** | $123 | $**342** | $248 |
| **Consulting** |  |  |  |  |
| Compensation and benefits  | $**1398** | $1314 | $**2761** | $2628 |
| Other operating expenses | **517** | 492 | **1012** | 960 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total expenses | $**1915** | $1806 | $**3773** | $3588 |
| Depreciation and amortization expense | $**25** | $26 | $**49** | $63 |
| Identified intangible amortization expense | **19** | 12 | **38** | 23 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $**44** | $38 | $**87** | $86 |

---

------

**Marsh & McLennan Companies, Inc.** 

**Consolidated Balance Sheets**

(Millions)

---

| | | |
|:---|:---|:---|
| | **(Unaudited)<br>June 30, <br>2025** | December 31,<br>2024 |
| **ASSETS** |  |  |
| Current assets: |  |  |
| Cash and cash equivalents | $**1677** | $2398 |
| Cash and cash equivalents held in a fiduciary capacity | **11871** | 11276 |
| Net receivables | **8457** | 7156 |
| Other current assets | **1329** | 1287 |
| **Total current assets** | **23334** | 22117 |
| Goodwill and intangible assets | **28689** | 28126 |
| Fixed assets, net | **839** | 859 |
| Pension related assets | **2203** | 1914 |
| Right of use assets | **1471** | 1498 |
| Deferred tax assets | **280** | 237 |
| Other assets | **1739** | 1730 |
| &nbsp;&nbsp;&nbsp;&nbsp;**TOTAL ASSETS** | $**58555** | $56481 |
| **LIABILITIES AND EQUITY** |  |  |
| Current liabilities: |  |  |
| Short-term debt | $**769** | $519 |
| Accounts payable and accrued liabilities | **3434** | 3402 |
| Accrued compensation and employee benefits | **2372** | 3620 |
| Current lease liabilities | **335** | 325 |
| Accrued income taxes | **619** | 376 |
| Fiduciary liabilities | **11871** | 11276 |
| **Total current liabilities** | **19400** | 19518 |
| Long-term debt | **18960** | 19428 |
| Pension, post-retirement and post-employment benefits | **816** | 840 |
| Long-term lease liabilities | **1546** | 1590 |
| Liabilities for errors and omissions | **280** | 305 |
| Other liabilities | **1577** | 1265 |
| **Total equity** | **15976** | 13535 |
| &nbsp;&nbsp;&nbsp;&nbsp;**TOTAL LIABILITIES AND EQUITY** | $**58555** | $56481 |

---

------

**Marsh & McLennan Companies, Inc.** 

**Consolidated Statements of Cash Flows**

(Millions) (Unaudited)

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br> June 30,** | **Six Months Ended<br> June 30,** |
| | **2025** | 2024 |
| **Operating cash flows:** |  |  |
| Net income before non-controlling interests | $**2643** | $2564 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to cash provided by operations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **458** | 365 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash lease expense | **145** | 132 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | **210** | 193 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (gain) on investments, disposition of assets and other | **(29)** | (97) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation and employee benefits | **(1334)** | (1226) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for taxes, net of payments and refunds | **190** | 214 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net receivables | **(921)** | (1287) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other changes to assets and liabilities | **(31)** | (92) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contributions to pension and other benefit plans in excess of current year credit | **(117)** | (182) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | **(165)** | (150) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by (used for) operations** | **1049** | 434 |
| **Financing cash flows:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of treasury shares | **(600)** | (600) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from issuance of commercial paper | **150** | 749 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of debt | **—** | 988 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayments of debt | **(510)** | (1609) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net issuance of common stock from treasury shares | **33** | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net distributions of non-controlling interests and deferred/contingent consideration | **(77)** | (101) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends paid | **(810)** | (706) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fiduciary liabilities | **(19)** | 901 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by (used for) financing activities** | **(1833)** | (384) |
| **Investing cash flows:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | **(114)** | (167) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of long-term investments and other | **(18)** | (13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales of long-term investments | **84** | 14 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dispositions | **15** | 27 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions, net of cash and cash held in a fiduciary capacity acquired | **(62)** | (644) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by (used for) investing activities** | **(95)** | (783) |
| **Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity** | **753** | (269) |
| **Increase (Decrease) in cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity** | **(126)** | (1002) |
| **Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of period** | **13674** | 14152 |
| **Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of period** | $**13548** | $13150 |

---

---

| | | |
|:---|:---|:---|
| **Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity to the Consolidated Balance Sheets** | **Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity to the Consolidated Balance Sheets** | **Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity to the Consolidated Balance Sheets** |
| **Balance at June 30,** | **2025** | 2024 |
| *(In millions)* |  |  |
| Cash and cash equivalents | $**1677** | $1653 |
| Cash and cash equivalents held in a fiduciary capacity | **11871** | 11497 |
| Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | $**13548** | $13150 |

---

------

**Marsh & McLennan Companies, Inc.**

**Reconciliation of Non-GAAP Measures**

**Three Months Ended June 30** 

(Millions) (Unaudited)

*Non-GAAP revenue* isolates the impact of foreign exchange rate movements and certain transaction-related items from the current period GAAP revenue. The *non-GAAP revenue* measure is presented on a constant currency basis, excluding the impact of foreign currency fluctuations. The Company isolates the impact of foreign exchange rate movements period over period, by translating the current period foreign currency GAAP revenue into U.S. Dollars based on the difference in the current and corresponding prior period exchange rates. Similarly, certain other items such as acquisitions and dispositions, including transfers among businesses, may impact period over period comparisons of revenue and are consistently excluded from current and prior period GAAP revenues for comparability purposes. Percentage changes, referred to as *non-GAAP underlying revenue*, are calculated by dividing the period over period change in *non-GAAP revenue* by the prior period *non-GAAP revenue.* 

The following table provides the reconciliation of GAAP revenue to non-GAAP revenue:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 |
| Three Months Ended June 30, | **GAAP Revenue** | **Currency Impact** | **Acquisitions/<br>Dispositions/<br>Other Impact** | **Non-GAAP Revenue** | GAAP Revenue | Acquisitions/<br>Dispositions/<br>Other Impact | Non-GAAP Revenue |
| **Risk and Insurance Services** |  |  |  |  |  |  |  |
| Marsh (a) | $**3849** | $**(18)** | $**(402)** | $**3429** | $3265 | $(5) | $3260 |
| Guy Carpenter | **677** | **(6)** | **(7)** | **664** | 632 | **—** | 632 |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | **4526** | **(24)** | **(409)** | **4093** | 3897 | (5) | 3892 |
| Fiduciary interest income | **99** | **—** | **(5)** | **94** | 125 | **—** | 125 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Risk and Insurance Services | **4625** | **(24)** | **(414)** | **4187** | 4022 | (5) | 4017 |
| **Consulting** |  |  |  |  |  |  |  |
| Mercer | **1498** | **(17)** | **(66)** | **1415** | 1379 | (5) | 1374 |
| Oliver Wyman Group | **873** | **(11)** | **(3)** | **859** | 837 | (5) | 832 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Consulting | **2371** | **(28)** | **(69)** | **2274** | 2216 | (10) | 2206 |
| **Corporate Eliminations** | **(22)** | **—** | **—** | **(22)** | (17) | **—** | (17) |
| &nbsp;&nbsp;&nbsp;**Total Revenue** | $**6974** | $**(52)** | $**(483)** | $**6439** | $6221 | $(15) | $6206 |

---

**Revenue Details**

The following table provides more detailed revenue information for certain of the components presented above:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 |
| Three Months Ended June 30, | **GAAP Revenue** | **Currency Impact** | **Acquisitions/<br>Dispositions/<br>Other Impact** | **Non-GAAP Revenue** | GAAP Revenue | Acquisitions/<br>Dispositions/<br>Other Impact | Non-GAAP Revenue |
| **Marsh:** |  |  |  |  |  |  |  |
| EMEA | $**1006** | $**(24)** | $**2** | $**984** | $912 | $(2) | $910 |
| Asia Pacific | **409** | **(2)** | **2** | **409** | 391 | (2) | 389 |
| Latin America | **132** | **7** | **2** | **141** | 137 | **—** | 137 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total International | **1547** | **(19)** | **6** | **1534** | 1440 | (4) | 1436 |
| U.S./Canada (a) | **2302** | **1** | **(408)** | **1895** | 1825 | (1) | 1824 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Marsh | $**3849** | $**(18)** | $**(402)** | $**3429** | $3265 | $(5) | $3260 |
| **Mercer:** |  |  |  |  |  |  |  |
| Wealth | $**685** | $**(11)** | $**(52)** | $**622** | $612 | $(4) | $608 |
| Health | **594** | **(3)** | **(8)** | **583** | 547 | (1) | 546 |
| Career | **219** | **(3)** | **(6)** | **210** | 220 |  | 220 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Mercer | $**1498** | $**(17)** | $**(66)** | $**1415** | $1379 | $(5) | $1374 |
| (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff. |
| Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  |

---

------

**Marsh & McLennan Companies, Inc.**

**Reconciliation of Non-GAAP Measures**

**Six Months Ended June 30** 

(Millions) (Unaudited)

The following table provides the reconciliation of GAAP revenue to non-GAAP revenue:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 |
| Six Months Ended June 30, | **GAAP Revenue** | **Currency Impact** | **Acquisitions/<br>Dispositions/<br>Other Impact** | **Non-GAAP Revenue** | GAAP Revenue | Acquisitions/<br>Dispositions/<br>Other Impact | Non-GAAP Revenue |
| **Risk and Insurance Services** |  |  |  |  |  |  |  |
| Marsh (a) | $**7302** | $**35** | $**(767)** | $**6570** | $6268 | $(13) | $6255 |
| Guy Carpenter | **1883** | **7** | **(22)** | **1868** | 1780 |  | 1780 |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | **9185** | **42** | **(789)** | **8438** | 8048 | (13) | 8035 |
| Fiduciary interest income | **202** | **1** | **(10)** | **193** | 247 |  | 247 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Risk and Insurance Services | **9387** | **43** | **(799)** | **8631** | 8295 | (13) | 8282 |
| **Consulting** |  |  |  |  |  |  |  |
| Mercer (b) | **2994** | **15** | **(136)** | **2873** | 2804 | (27) | 2777 |
| Oliver Wyman Group | **1691** | **(3)** | **(12)** | **1676** | 1626 | (9) | 1617 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Consulting | **4685** | **12** | **(148)** | **4549** | 4430 | (36) | 4394 |
| **Corporate Eliminations** | **(37)** | **—** | **—** | **(37)** | (31) |  | (31) |
| &nbsp;&nbsp;&nbsp;**Total Revenue** | $**14035** | $**55** | $**(947)** | $**13143** | $12694 | $(49) | $12645 |

---

**Revenue Details**

The following table provides more detailed revenue information for certain of the components presented above:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 |
| Six Months Ended June 30, | **GAAP Revenue** | **Currency Impact** | **Acquisitions/<br>Dispositions/<br>Other Impact** | **Non-GAAP Revenue** | GAAP Revenue | Acquisitions/<br>Dispositions/<br>Other Impact | Non-GAAP Revenue |
| **Marsh:** |  |  |  |  |  |  |  |
| EMEA | $**2065** | $**4** | $**4** | $**2073** | $1937 | $(3) | $1934 |
| Asia Pacific | **744** | **6** | **2** | **752** | 727 | (6) | 721 |
| Latin America | **256** | **18** | **2** | **276** | 262 |  | 262 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total International | **3065** | **28** | **8** | **3101** | 2926 | (9) | 2917 |
| U.S./Canada (a) | **4237** | **7** | **(775)** | **3469** | 3342 | (4) | 3338 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Marsh | $**7302** | $**35** | $**(767)** | $**6570** | $6268 | $(13) | $6255 |
| **Mercer:** |  |  |  |  |  |  |  |
| Wealth (b) | $**1355** | $**4** | $**(112)** | $**1247** | $1284 | $(70) | $1214 |
| Health (b) | **1202** | **9** | **(8)** | **1203** | 1085 | 43 | 1128 |
| Career | **437** | **2** | **(16)** | **423** | 435 |  | 435 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Mercer | $**2994** | $**15** | $**(136)** | $**2873** | $2804 | $(27) | $2777 |
| (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff.<br>(b)Acquisitions, dispositions and other in 2024 includes a net gain of $21 million from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a $66 million gain in Wealth, offset by a $45 million loss in Health. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff.<br>(b)Acquisitions, dispositions and other in 2024 includes a net gain of $21 million from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a $66 million gain in Wealth, offset by a $45 million loss in Health. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff.<br>(b)Acquisitions, dispositions and other in 2024 includes a net gain of $21 million from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a $66 million gain in Wealth, offset by a $45 million loss in Health. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff.<br>(b)Acquisitions, dispositions and other in 2024 includes a net gain of $21 million from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a $66 million gain in Wealth, offset by a $45 million loss in Health. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff.<br>(b)Acquisitions, dispositions and other in 2024 includes a net gain of $21 million from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a $66 million gain in Wealth, offset by a $45 million loss in Health. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff.<br>(b)Acquisitions, dispositions and other in 2024 includes a net gain of $21 million from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a $66 million gain in Wealth, offset by a $45 million loss in Health. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff.<br>(b)Acquisitions, dispositions and other in 2024 includes a net gain of $21 million from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a $66 million gain in Wealth, offset by a $45 million loss in Health. | (a)Acquisitions, dispositions and other in 2025 includes the impact of McGriff.<br>(b)Acquisitions, dispositions and other in 2024 includes a net gain of $21 million from the sale of the U.K. pension administration and U.S. health and benefits administration businesses, that comprised of a $66 million gain in Wealth, offset by a $45 million loss in Health. |
| Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  | Note: Amounts in the tables above are rounded to whole numbers.  |

---